VeriMomSollte ich lithium hydroxide in der Schwangerschaft meiden? | VeriMom
ECHA/RAC has proposed harmonised classification for lithium hydroxide as reproductive toxicant (Repr. 1A, H360—may damage fertility/unborn child) and lactation (H362); regulatory bodies and risk assessments driving that proposal cite mammalian data and human lithium drug literature showing placental transfer and developmental effects. This supports a confirmed hazard (H360 → h=3) and a demonstrated mechanism (placental transfer / developmental signalling effects from lithium). Topical cosmetic exposure would give low but measurable systemic exposure in normal use (hence e=1). (Sources: ECHA registry and RAC/ANSES material; PubMed reviews on lithium exposure in pregnancy).
ECHA regulatory hazard statements
- •H360
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- Ist lithium hydroxide in der Schwangerschaft sicher?
- ECHA/RAC has proposed harmonised classification for lithium hydroxide as reproductive toxicant (Repr. 1A, H360—may damage fertility/unborn child) and lactation (H362); regulatory bodies and risk assessments driving that proposal cite mammalian data and human lithium drug literature showing placental transfer and developmental effects. This supports a confirmed hazard (H360 → h=3) and a demonstrated mechanism (placental transfer / developmental signalling effects from lithium). Topical cosmetic exposure would give low but measurable systemic exposure in normal use (hence e=1). (Sources: ECHA registry and RAC/ANSES material; PubMed reviews on lithium exposure in pregnancy).
- Ist lithium hydroxide während des Stillens sicher?
- RAC/ANSES proposals include a lactation hazard (H362) for lithium salts; clinical/literature on therapeutic lithium shows transfer into breastmilk and effects on breastfed infants, supporting a confirmed hazard (h=3) and demonstrated mechanism (maternal→milk transfer). Topical cosmetic use is expected to give low but measurable maternal systemic exposure (e=1) unless formulations/uses provide negligible absorption. (Sources: ECHA/ANSES/RAC documentation; PubMed clinical reviews on lithium and breastfeeding).
- Ist lithium hydroxide sicher für Babyhaut?
- Hazard and mechanism remain driven by the same lithium salt evidence (RAC proposal Repr.1A/H360 and lactation H362; systemic lithium crosses placenta and is secreted in milk). Because infant skin (0–3 yr) has higher surface-area-to-weight and a less mature barrier, exposure score is increased by +1 (adult e=1 → infant e=2). There is no infant-specific evidence changing hazard or mechanism, but increased dermal exposure potential supports higher exposure concern for babies. (Sources: ECHA/ANSES/RAC; PubMed literature on lithium transfer and infant effects; CosIng listing and restriction notes).
- Wie bewertet VeriMom lithium hydroxide?
- VeriMom bewertet lithium hydroxide mit 20/100 (hohes Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu lithium hydroxide?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu lithium hydroxide basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.